Canada markets open in 8 hours 15 minutes

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
38.20+0.95 (+2.55%)
At close: 04:00PM EDT
38.20 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 401.38M
Enterprise Value 401.35M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.49k
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -9.03

Trading Information

Stock Price History

Beta (5Y Monthly) 2.47
52-Week Change 3254.42%
S&P500 52-Week Change 321.33%
52 Week High 349.87
52 Week Low 33.03
50-Day Moving Average 337.07
200-Day Moving Average 315.38

Share Statistics

Avg Vol (3 month) 3284.81k
Avg Vol (10 day) 3189.06k
Shares Outstanding 510.51M
Implied Shares Outstanding 610.51M
Float 86.77M
% Held by Insiders 10.69%
% Held by Institutions 159.59%
Shares Short (Apr 15, 2024) 4623.06k
Short Ratio (Apr 15, 2024) 42.5
Short % of Float (Apr 15, 2024) 47.36%
Short % of Shares Outstanding (Apr 15, 2024) 45.93%
Shares Short (prior month Mar 15, 2024) 4403.79k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Feb 14, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-59.57%
Return on Equity (ttm)-341.98%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -44.44M
Net Income Avi to Common (ttm)-44.6M
Diluted EPS (ttm)-10.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.91M
Total Cash Per Share (mrq)1.99
Total Debt (mrq)20.88M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.74
Book Value Per Share (mrq)-1.56

Cash Flow Statement

Operating Cash Flow (ttm)-36.1M
Levered Free Cash Flow (ttm)-21.24M